| URL | https://www.in-pharmatechnologist.com/Article/2017 |
| Source | in-Pharma Technologist.com |
| Date Published | 10/11/2017 |
| Author Name | Flora Southey |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Piramal Pharma Solutions |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2017 |
| Year reshoring implemented or to be implemented: | 2018 |
| Capital investment ($): | 55 |
| Country(ies) from which reshored: | India |
| City reshored to: | Riverview |
| State(s) reshored to: | MI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharmaceutical ingredients |